Search Results - "ALEIL, B."

Refine Results
  1. 1

    Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases by ALEIL, B., RAVANAT, C., CAZENAVE, J. P., ROCHOUX, G., HEITZ, A., GACHET, C.

    Published in Journal of thrombosis and haemostasis (01-01-2005)
    “…Interindividual variability of the inhibitory effect of clopidogrel on platelet functions leading to clopidogrel resistance has been described in some patients…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy by Kamath, S., Blann, A. D., Chin, B. S. P., Lanza, F., Aleil, B., Cazenave, J. P., Lip, G. Y. H.

    Published in European heart journal (01-11-2002)
    “…Background Platelet function may be abnormal in patients with atrial fibrillation (AF) and could be related to abnormal thrombogenesis. The aim of this…”
    Get full text
    Journal Article
  5. 5
  6. 6

    In vitro evaluation of Haemonetics MCS+ apheresis platelet concentrates treated with photochemical pathogen inactivation following plasma volume reduction using the INTERCEPT Preparation Set by Isola, H., Kientz, D., Aleil, B., Laeuffer, P., Weil, J., Wiesel, M.-L., Laforêt, M., Lin, L., Mayaudon, V., Cazenave, J.-P.

    Published in Vox sanguinis (01-02-2006)
    “…Pathogen inactivation using the INTERCEPT Blood System™ requires platelet resuspension in InterSol™ and reduced plasma. Platelets in plasma collected on the…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    P48 Étude de la glycoprotéine V soluble plaquettaire au cours du syndrome d’apnée du sommeil chez le patient obèse by Aleil, B, Laurent, T, Kessler, R, Weitzenblum, E, Pinget, M, Lanza, F, Kessler, L

    Published in Diabetes & metabolism (2009)
    “…Introduction Le syndrome d’apnée du sommeil (SAS) est un facteur de risque cardio vasculaire. Il est fréquemment associé au diabète de type 2. La glycoprotéine…”
    Get full text
    Journal Article
  10. 10

    Platelet-Derived Serotonin Mediates Liver Regeneration by Lesurtel, Mickael, Graf, Rolf, Aleil, Boris, Walther, Diego J, Tian, Yinghua, Jochum, Wolfram, Gachet, Christian, Bader, Michael, Clavien, Pierre-Alain

    “…The liver can regenerate its volume after major tissue loss. In a mouse model of liver regeneration, thrombocytopenia, or impaired platelet activity resulted…”
    Get full text
    Journal Article
  11. 11

    Sensitivity and long‐term prognostic value of cardiac troponin‐i increase shortly after percutaneous transluminal coronary angioplasty by Attali, P., Aleil, B., Depoli, F., Mossard, J. M., Wiesel, M. L., Petitpas, G., Wuillermin, A., Cazenave, J. P.

    Published in Clinical cardiology (Mahwah, N.J.) (01-05-1998)
    “…Background: After successful coronary interventions, minor elevations of creatine kinase MB (CK‐MB) identified a population with a worse long‐term prognosis…”
    Get full text
    Journal Article
  12. 12

    Prospective study of the new oral anticoagulants in private practice: cautious optimism by Krieger, C, Stephan, D, Aleil, B

    Published in Annales de cardiologie et d'angeiologie (01-04-2015)
    “…The new direct oral anticoagulants (DOA) such as dabigatran, rivaroxaban or apixaban are an evolution in the management of patients requiring curative…”
    Get more information
    Journal Article
  13. 13

    Actualités en transfusion sur la conservation des plaquettes by Cazenave, J.-P., Isola, H., Gachet, C., Aleil, B.

    “…L'amélioration de l'efficacité et de la sécurité des concentrés plaquettaires dépend des conditions de conservation et de leur amélioration : conservation au…”
    Get full text
    Journal Article Conference Proceeding
  14. 14

    Stress pharmacologique cardiaque par Régadénoson chez les patients traités par Ticagrélor : étude préliminaire concernant les effets secondaires by Blondet, C., Aleil, B., El Ghannudi, S., Namer, I.J.

    “…Le ticagrélor (Brilique®) est un anti-agrégant plaquettaire de la classe des CPTP (cyclo-pentyl-triazolo-pyrimidines). Fréquemment associé à l’aspirine, cet…”
    Get full text
    Journal Article
  15. 15

    Effets secondaires d’un stress par Régadénoson en scintigraphie myocardique chez les patients traités par Ticagrélor by Tauty, A., Aleil, B., Verdun, A., Abbo, S.E.G., Lefevbre, F., Namer, I.J., Imperiale, A., Blondet, C.

    “…Le Ticagrélor, antiagrégant plaquettaire, est un inhibiteur de la recapture de l’adénosine par les hématies. Le Régadénoson, agoniste de l’adénosine, constitue…”
    Get full text
    Journal Article
  16. 16

    Enquête prospective sur les nouveaux anticoagulants oraux en médecine libérale : un enthousiasme prudent by Krieger, C., Stephan, D., Aleil, B.

    Published in Annales de cardiologie et d'angéiologie (01-04-2015)
    “…La mise à disposition des anticoagulants oraux directs (AOD) comme le dabigatran, le rivaroxaban, l’apixaban constitue une évolution dans la prise en charge…”
    Get full text
    Journal Article
  17. 17

    Syndrome de Takotsubo de découverte fortuite : étude échocardiographique et scintigraphique (99 mTc-tétrofosmine, 123I-mIBG et 18F-FDG) by Blondet, C., Heimburger, C., Namer, I.-J., Aleil, B.

    “…Le syndrome de Takotsubo se caractérise habituellement par une présentation mimant cliniquement et électriquement un syndrome coronaire aigu, avec…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Soluble platelet glycoprotein V is a marker of thrombosis in patients with ischemic stroke by Wolff, Valérie, Aleil, Boris, Giroud, Maurice, Lorenzini, Jean-Louis, Meyer, Nicolas, Wiesel, Marie-Louise, Cazenave, Jean-Pierre, Lanza, François

    Published in Stroke (1970) (01-03-2005)
    “…The diagnosis and management of patients with acute ischemic stroke still lack an informative biochemical test. Soluble glycoprotein V (sGPV) is a new…”
    Get full text
    Journal Article
  20. 20

    Progress in transfusion for storage of platelets by Cazenave, J-P, Isola, H, Gachet, C, Aleil, B

    “…Improvement of platelet concentrates efficacy and safety depends on platelet storage conditions and their improvement: storage in the cold, additive solutions…”
    Get full text
    Journal Article